CS

Craig Sherman

Managing Director Meritech Capital Partners

Atherton, California

Overview

Work Experience

  • Managing Director

    2011 - Current

    Helping entrepreneurs grow great companies they can tell their grandkids about.

  • Board Observer

    2018

    Serge, Ben and Kevin built and took public a company that is revolutionizing multiple areas of biology - no hyperbole. The 10x teams work is already leading to life-saving discoveries and will ultimately impact hundreds of millions of lives.

  • Investor

    2017

  • Board Observer

    2012

  • Angel Investor

    2011

  • Angel Investor

    2010

    Tom and team are the first to ever create micro-stents to treat Glaucoma. The stents are tiny (the smallest medical devices ever approved by the FDA and nearly invisible to the naked eye) but Glaukos'​ impact on people's sight is huge. Glaukos went public in 2015 (GKOS).

  • Angel Investor

    2010

  • Board Member and Angel Investor

    2007

  • Angel Investor

    2011

  • Angel Investor

    2012

Education

Relevant Websites